{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:36:43Z","timestamp":1777354603209,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.amepre.2016.10.023","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T08:48:19Z","timestamp":1481705299000},"page":"769-777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Predictors of Mortality Among U.S. Veterans With Streptococcus Pneumoniae Infections"],"prefix":"10.1016","volume":"52","author":[{"given":"Jacob B.","family":"Morton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haley J.","family":"Morrill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerry L.","family":"LaPlante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisling R.","family":"Caffrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amepre.2016.10.023_bib1","unstructured":"CDC. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Surveillance reports: Streptococcus pneumoniae; 2002-2013. www.cdc.gov\/abcs\/reports-findings\/surv-reports.html. Accessed March 1, 2016."},{"key":"10.1016\/j.amepre.2016.10.023_bib2","series-title":"Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases","first-page":"2310","article-title":"Streptococcus pneumoniae","author":"Janoff","year":"2015"},{"key":"10.1016\/j.amepre.2016.10.023_bib3","series-title":"Epidemiology and prevention of vaccine-preventable diseases","year":"2012"},{"key":"10.1016\/j.amepre.2016.10.023_bib4","unstructured":"CDC. Pneumococcal disease: fast facts. 2015. www.cdc.gov\/pneumococcal\/about\/facts.html. Accessed March 1, 2016."},{"issue":"18","key":"10.1016\/j.amepre.2016.10.023_bib5","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1016\/j.vaccine.2011.02.088","article-title":"Healthcare utilization and cost of pneumococcal disease in the United States","volume":"29","author":"Huang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2016.10.023_bib6","unstructured":"Veterans Health Administration. Where do I get the care I need? 2015. www.va.gov\/health\/FindCare.asp. Accessed June 3, 2015"},{"issue":"1","key":"10.1016\/j.amepre.2016.10.023_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40121-014-0025-y","article-title":"Epidemiology of pneumococcal disease in a national cohort of older adults","volume":"3","author":"Morrill","year":"2014","journal-title":"Infect Dis Ther"},{"issue":"4","key":"10.1016\/j.amepre.2016.10.023_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/NAQ.0000000000000118","article-title":"The Veteran\u2019s Affairs Corporate Data Warehouse","volume":"39","author":"Price","year":"2015","journal-title":"Nurs Admin Q"},{"issue":"14","key":"10.1016\/j.amepre.2016.10.023_bib9","first-page":"129","article-title":"Pneumococcal vaccines: WHO position paper","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.amepre.2016.10.023_bib10","series-title":"Applied Logistic Regression","author":"Hosmer","year":"2005"},{"issue":"18","key":"10.1016\/j.amepre.2016.10.023_bib11","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJMoa040845","article-title":"Clinical features and prognostic factors in adults with bacterial meningitis","volume":"351","author":"van de Beek","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.amepre.2016.10.023_bib12","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1086\/315760","article-title":"Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries","volume":"182","author":"Kalin","year":"2000","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.amepre.2016.10.023_bib13","doi-asserted-by":"crossref","first-page":"e0147877","DOI":"10.1371\/journal.pone.0147877","article-title":"Host factors and biomarkers associated with poor outcomes in adults with invasive pneumococcal disease","volume":"11","author":"Hanada","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.amepre.2016.10.023_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1532-5415.2005.00528.x","article-title":"Characteristics and outcomes of older adults with community-acquired pneumococcal bacteremia","volume":"54","author":"Chi","year":"2006","journal-title":"J Am Geriatr Soc"},{"issue":"49","key":"10.1016\/j.amepre.2016.10.023_bib15","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1016\/j.vaccine.2013.09.049","article-title":"Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011","volume":"31","author":"Rudnick","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.amepre.2016.10.023_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijantimicag.2010.04.001","article-title":"Comparison of clinical features, antimicrobial susceptibility, serotype distribution and outcomes of patients with hospital- and community-associated invasive pneumococcal disease","volume":"36","author":"Lin","year":"2010","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.amepre.2016.10.023_bib17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1086\/520209","article-title":"Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence","volume":"29","author":"Turett","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.amepre.2016.10.023_bib18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01.md.0000180045.26909.29","article-title":"Streptococcus pneumoniae bacteremia in patients with cancer: disease characteristics and outcomes in the era of escalating drug resistance (1998-2002)","volume":"84","author":"Kumashi","year":"2005","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.amepre.2016.10.023_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/cid\/civ803","article-title":"Invasive pneumococcal disease among immunocompromised persons: implications for vaccination programs","volume":"62","author":"Shigayeva","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.amepre.2016.10.023_bib20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/431521","article-title":"The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults","volume":"192","author":"Kyaw","year":"2005","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.amepre.2016.10.023_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000070405","article-title":"Impact of pneumococcal vaccination on morbidity and mortality of geriatric patients: a case-controlled study","volume":"49","author":"Wagner","year":"2003","journal-title":"Gerontology"},{"issue":"1","key":"10.1016\/j.amepre.2016.10.023_bib22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.vaccine.2014.10.073","article-title":"Impact of a combined pediatric and adult pneumococcal immunization program on adult pneumonia incidence and mortality in Nicaragua","volume":"33","author":"Becker-Dreps","year":"2015","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.amepre.2016.10.023_bib23","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1086\/507340","article-title":"Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study","volume":"43","author":"Vila-Corcoles","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amepre.2016.10.023_bib24","unstructured":"Office of Disease Prevention and Health Promotion. Healthy People 2020. Immunization and infectious diseases. 2016. www.healthypeople.gov\/2020\/topics-objectives\/topic\/immunization-and-infectious-diseases\/objectives#4658. Accessed February 24, 2016."},{"key":"10.1016\/j.amepre.2016.10.023_bib25","unstructured":"CDC. National Health Interview Survey. 2013. www.cdc.gov\/nchs\/nhis\/nhis_2013_data_release.htm. Accessed February 24, 2016."},{"issue":"13","key":"10.1016\/j.amepre.2016.10.023_bib26","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.285.13.1729","article-title":"Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era","volume":"285","author":"Robinson","year":"2001","journal-title":"JAMA"},{"issue":"40","key":"10.1016\/j.amepre.2016.10.023_bib27","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"61","year":"2012","journal-title":"MMWR Morb Mort Wkly Rep"},{"issue":"6 suppl 4","key":"10.1016\/j.amepre.2016.10.023_bib28","doi-asserted-by":"crossref","first-page":"S383","DOI":"10.1016\/j.amepre.2015.09.008","article-title":"Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines","volume":"49","author":"Pilishvili","year":"2015","journal-title":"Am J Prev Med"},{"issue":"7","key":"10.1016\/j.amepre.2016.10.023_bib29","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1080\/21645515.2015.1043502","article-title":"Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adults","volume":"11","author":"Isturiz","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.amepre.2016.10.023_bib30","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/thoraxjnl-2013-204282","article-title":"Risk factors for community-acquired pneumonia in adults in Europe: a literature review","volume":"68","author":"Torres","year":"2013","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.amepre.2016.10.023_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1681\/ASN.2007050554","article-title":"Renal impairment predicts long-term mortality risk after acute myocardial infarction","volume":"19","author":"Smith","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.amepre.2016.10.023_bib32","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.amjcard.2008.11.033","article-title":"Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry)","volume":"103","author":"Cardarelli","year":"2009","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.amepre.2016.10.023_bib33","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/WON.0b013e3182a22032","article-title":"Pressure ulcer prevalence, use of preventive measures, and mortality risk in an acute care population: a quality improvement project","volume":"40","author":"Leijon","year":"2013","journal-title":"J Wound Ostomy Continence Nurs"},{"issue":"3","key":"10.1016\/j.amepre.2016.10.023_bib34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2169\/internalmedicine.52.8830","article-title":"Etiology and factors contributing to the severity and mortality of community-acquired pneumonia","volume":"52","author":"Ishiguro","year":"2013","journal-title":"Intern Med"},{"key":"10.1016\/j.amepre.2016.10.023_bib35","unstructured":"Alzheimer\u2019s Association. 2014 Alzheimer\u2019s disease: facts and figures. 2014. https:\/\/www.alz.org\/downloads\/facts_figures_2014.pdf. Accessed April 13, 2016."},{"issue":"3","key":"10.1016\/j.amepre.2016.10.023_bib36","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MCP.0000000000000261","article-title":"Cardiovascular disease as a complication of community-acquired pneumonia","volume":"22","author":"Rae","year":"2016","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"10.1016\/j.amepre.2016.10.023_bib37","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00005792-200007000-00002","article-title":"Bacteremic and nonbacteremic pneumococcal pneumonia: a prospective study","volume":"79","author":"Musher","year":"2000","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.amepre.2016.10.023_bib38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/520200","article-title":"Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity","volume":"29","author":"Romero-Steiner","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amepre.2016.10.023_bib39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/1471-2458-12-222","article-title":"Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAMPAMIS study, one-year follow-up","volume":"12","author":"Vila-Corcoles","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.amepre.2016.10.023_bib40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2334-10-73","article-title":"Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years and older","volume":"10","author":"Vila-Corcoles","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"21","key":"10.1016\/j.amepre.2016.10.023_bib41","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1001\/archinte.160.21.3252","article-title":"Are patients at Veterans Affairs medical centers sicker? A comparative analysis of health status and medical resource use","volume":"160","author":"Agha","year":"2000","journal-title":"Arch Intern Med"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379716305487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379716305487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T21:25:09Z","timestamp":1536182709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379716305487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0749379716305487"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2016.10.023","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of Mortality Among U.S. Veterans With Streptococcus Pneumoniae Infections","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2016.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine","name":"copyright","label":"Copyright"}]}}